Reversible posterior leukoencephalopathy syndrome after rituximab

American Journal of Emergency Medicine

Volumn 28, Issue 4, 2010, Pages 537.e1-537.e2

  Zito, Joseph A ^a   Lee, Christopher C ^a   Johnson, Scott ^a   Singer, Adam ^a   Vacirca, Jeffrey ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; HYDROMORPHONE; IMMUNOGLOBULIN; RITUXIMAB; STEROID; WARFARIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ERYTHROCYTE APLASIA; FALLING; FEMALE; HEADACHE; HEPATITIS C; HOSPITAL DISCHARGE; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; LUNG EMBOLISM; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

EID: 77951911392     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2009.04.019     Document Type: Article

References (4)

1. Hinchey J., Chaves C., Appignani B., Breen J., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334 (1996) 494-500
2. Bechstein W.O. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transplant Int 13 (2000) 313-326
3. Wijdicks E.F. Neurotoxicity of immunosuppressive drugs. Liver Transplant 7 (2001) 937-942
4. Garg R.K. Posterior leukoencephalopathy syndrome. Postgrad Med J 77 (2001) 24-28